{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T20:38:24Z","timestamp":1763584704483},"reference-count":98,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","medical.theclinics.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.mcna.2016.03.008","type":"journal-article","created":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T04:42:27Z","timestamp":1464237747000},"page":"763-789","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pharmacologic Therapies in Women\u2019s Health"],"prefix":"10.1016","volume":"100","author":[{"given":"Caitlin","family":"Allen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ginger","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliza L.","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.mcna.2016.03.008_bib1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1155\/2006\/859435","article-title":"Pharmacological therapy of vascular malformations of the gastrointestinal tract","volume":"20","author":"Szilagyi","year":"2006","journal-title":"Can J Gastroenterol"},{"issue":"6","key":"10.1016\/j.mcna.2016.03.008_bib2","first-page":"673","article-title":"Biologic effects of various doses of ethinyl estradiol in postmenopausal women","volume":"59","author":"Mandel","year":"1982","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.mcna.2016.03.008_bib3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.contraception.2009.06.005","article-title":"Forgettable contraception","volume":"80","author":"Grimes","year":"2009","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.mcna.2016.03.008_bib4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.contraception.2011.01.021","article-title":"Contraceptive failure in the United States","volume":"83","author":"Trussell","year":"2011","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.mcna.2016.03.008_bib5","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.contraception.2015.01.002","article-title":"Benchmark pregnancy rates and the assessment of post-coital contraceptives: an update","volume":"91","author":"Li","year":"2015","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.mcna.2016.03.008_bib6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0010-7824(01)00191-3","article-title":"Likelihood of conception with a single act of intercourse: providing benchmark rates for assessment of post-coital contraceptives","volume":"63","author":"Wilcox","year":"2001","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.mcna.2016.03.008_bib7","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/j.1875-9114.2012.01041.x","article-title":"Measuring and reporting of the treatment effect of hormonal emergency contraceptives","volume":"32","author":"Leung","year":"2012","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.mcna.2016.03.008_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0010-7824(01)00231-1","article-title":"Emergency contraception with Multiload Cu-375 SL IUD: a multicenter clinical trial","volume":"64","author":"Zhou","year":"2001","journal-title":"Contraception"},{"issue":"7","key":"10.1016\/j.mcna.2016.03.008_bib9","first-page":"1994","article-title":"The efficacy of intrauterine devices for emergency contraception: a systematic review of 35 years of experience","volume":"27","author":"Cleland","year":"2012","journal-title":"Hum\u00a0Reprod"},{"issue":"10","key":"10.1016\/j.mcna.2016.03.008_bib10","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/j.1471-0528.2010.02652.x","article-title":"Copper T380A intrauterine device for emergency contraception: a prospective, multicentre, cohort clinical trial","volume":"117","author":"Wu","year":"2010","journal-title":"BJOG"},{"issue":"9714","key":"10.1016\/j.mcna.2016.03.008_bib11","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0140-6736(10)60101-8","article-title":"Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis","volume":"375","author":"Glasier","year":"2010","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.mcna.2016.03.008_bib12","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/AOG.0b013e3182a91f45","article-title":"Twenty-four-month continuation of reversible contraception","volume":"122","author":"O'neil-Callahan","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.mcna.2016.03.008_bib13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/AOG.0b013e318227f05e","article-title":"ACOG Practice Bulletin No. 121: Long-acting reversible contraception: Implants and intrauterine devices","volume":"118","author":"American College of Obstetricians and Gynecologists","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"21","key":"10.1016\/j.mcna.2016.03.008_bib14","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa1110855","article-title":"Effectiveness of long-acting reversible contraception","volume":"366","author":"Winner","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.mcna.2016.03.008_bib15","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.contraception.2014.02.011","article-title":"Extended use of the intrauterine device: a literature review and recommendations for clinical practice","volume":"89","author":"Wu","year":"2014","journal-title":"Contraception"},{"issue":"11","key":"10.1016\/j.mcna.2016.03.008_bib16","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1093\/humrep\/dev221","article-title":"A\u00a03-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls","volume":"30","author":"Bahamondes","year":"2015","journal-title":"Hum Reprod"},{"issue":"7","key":"10.1016\/j.mcna.2016.03.008_bib17","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1093\/humrep\/deu089","article-title":"A\u00a0randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives","volume":"29","author":"Modesto","year":"2014","journal-title":"Hum Reprod"},{"issue":"188","key":"10.1016\/j.mcna.2016.03.008_bib18","first-page":"1","article-title":"Trends in long-acting reversible contraception use among U.S. women aged 15-44","author":"Branum","year":"2015","journal-title":"NCHS Data Brief"},{"issue":"2","key":"10.1016\/j.mcna.2016.03.008_bib19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pop.2014.02.004","article-title":"Prevention of unintended pregnancy: a focus on long-acting reversible contraception","volume":"41","author":"Pickle","year":"2014","journal-title":"Prim Care"},{"key":"10.1016\/j.mcna.2016.03.008_bib20","doi-asserted-by":"crossref","first-page":"811","DOI":"10.2147\/IJWH.S53845","article-title":"Intrauterine contraception after cesarean section and during lactation: a systematic review","volume":"5","author":"Goldstuck","year":"2013","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.mcna.2016.03.008_bib21","unstructured":"FDA Product. Intrauterine copper contraceptive. Available at: http:\/\/www.iodine.com\/label\/paragard-t-380a. Accessed November 29, 2015."},{"issue":"1","key":"10.1016\/j.mcna.2016.03.008_bib22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3109\/13625187.2014.971454","article-title":"Intrauterine device insertion in the postpartum period: A systematic review","volume":"20","author":"Sonalkar","year":"2015","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.mcna.2016.03.008_bib23","unstructured":"MIRENA. Available at: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2008\/021225s019lbl.pdf. Accessed November 22, 2015."},{"key":"10.1016\/j.mcna.2016.03.008_bib24","unstructured":"Nexplanon. Available at: https:\/\/www.merck.com\/product\/usa\/pi_circulars\/n\/nexplanon\/nexplanon_pi.pdf. Accessed November 22, 2015."},{"issue":"3","key":"10.1016\/j.mcna.2016.03.008_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003988.pub2","article-title":"Combined hormonal versus nonhormonal versus progestin-only contraception in lactation","author":"Lopez","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.mcna.2016.03.008_bib26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/13625187.2015.1010639","article-title":"Fertility after intrauterine device removal: a pilot study","volume":"20","author":"Stoddard","year":"2015","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"4","key":"10.1016\/j.mcna.2016.03.008_bib27","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s13224-011-0066-z","article-title":"Implanon: subdermal single rod contraceptive implant","volume":"61","author":"Bhatia","year":"2011","journal-title":"J\u00a0Obstet Gynaecol India"},{"issue":"7","key":"10.1016\/j.mcna.2016.03.008_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008815.pub3","article-title":"Progestin-only contraceptives: effects on weight","author":"Lopez","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.mcna.2016.03.008_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009849.pub3","article-title":"Steroidal contraceptives and bone fractures in women: evidence from observational studies","author":"Lopez","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.mcna.2016.03.008_bib30","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/01.AOG.0000175144.08035.74","article-title":"Extended regimens of the contraceptive vaginal ring: a randomized trial","volume":"106","author":"Miller","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.mcna.2016.03.008_bib31","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/AOG.0b013e3181842071","article-title":"Frequency and management of breakthrough bleeding with continuous use of the transvaginal contraceptive ring: a randomized controlled trial","volume":"112","author":"Sulak","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.mcna.2016.03.008_bib32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.contraception.2010.11.002","article-title":"Extended regimens of the combined contraceptive vaginal ring containing etonogestrel and ethinyl estradiol: effects on lipid metabolism","volume":"84","author":"Barreiros","year":"2011","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.mcna.2016.03.008_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010813.pub2","article-title":"Combined oral contraceptives: venous thrombosis","author":"de Bastos","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.mcna.2016.03.008_bib34","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1158\/1055-9965.EPI-13-0298","article-title":"Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review","volume":"22","author":"Gierisch","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"10.1016\/j.mcna.2016.03.008_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004425.pub5","article-title":"Combined oral contraceptive pills for treatment of acne","author":"Arowojolu","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.mcna.2016.03.008_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002120.pub2","article-title":"Oral contraceptive pill as treatment for primary dysmenorrhoea","author":"Wong","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.mcna.2016.03.008_bib37","first-page":"341","article-title":"Diagnosis and initial management of dysmenorrhea","volume":"89","author":"Osayande","year":"2014","journal-title":"Am Fam Physician"},{"issue":"6","key":"10.1016\/j.mcna.2016.03.008_bib38","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.fertnstert.2011.02.045","article-title":"Evaluation of a low-dose oral contraceptive pill for primary dysmenorrhea: a placebo-controlled, double-blind, randomized trial","volume":"95","author":"Harada","year":"2011","journal-title":"Fertil Steril"},{"issue":"3 Pt 1","key":"10.1016\/j.mcna.2016.03.008_bib39","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0002-9378(98)70047-X","article-title":"Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons","volume":"179","author":"Rosenberg","year":"1998","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.mcna.2016.03.008_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003987.pub5","article-title":"Combination contraceptives: effects on weight","author":"Gallo","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"3 Pt 1","key":"10.1016\/j.mcna.2016.03.008_bib41","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ajog.2004.12.089","article-title":"Headache as a side effect of combination estrogen-progestin oral contraceptives: a systematic review","volume":"193","author":"Loder","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.mcna.2016.03.008_bib42","doi-asserted-by":"crossref","first-page":"e13628","DOI":"10.5812\/ircmj.13628","article-title":"A\u00a0comparison of second and third generations combined oral contraceptive pills\u2019 effect on mood","volume":"16","author":"Shahnazi","year":"2014","journal-title":"Iran Red Crescent Med J"},{"issue":"4","key":"10.1016\/j.mcna.2016.03.008_bib43","doi-asserted-by":"crossref","first-page":"e93792","DOI":"10.1371\/journal.pone.0093792","article-title":"Estimate of venous thromboembolism and related-deaths attributable to the use of combined oral contraceptives in France","volume":"9","author":"Tricotel","year":"2014","journal-title":"PLoS One"},{"issue":"24","key":"10.1016\/j.mcna.2016.03.008_bib44","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1056\/NEJMoa1111840","article-title":"Thrombotic Stroke and Myocardial Infarction with Hormonal Contraception","volume":"366","author":"Lidegaard","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"RR-4","key":"10.1016\/j.mcna.2016.03.008_bib45","first-page":"1","article-title":"U\u00a0S. Medical Eligibility Criteria for Contraceptive Use, 2010","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","journal-title":"MMWR Recomm Rep"},{"issue":"Suppl 6","key":"10.1016\/j.mcna.2016.03.008_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.17.S6.1","article-title":"American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of menopause","volume":"17","author":"Goodman","year":"2011","journal-title":"Endocr Pract"},{"issue":"7621","key":"10.1016\/j.mcna.2016.03.008_bib47","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/bmj.39289.649410.55","article-title":"Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner\u2019s oral contraception study","volume":"335","author":"Hannaford","year":"2007","journal-title":"BMJ"},{"issue":"RR-05","key":"10.1016\/j.mcna.2016.03.008_bib48","first-page":"1","article-title":"U.S. Selected Practice Recommendations for Contraceptive Use, 2013: adapted from the World Health Organization selected practice recommendations for contraceptive use, 2nd edition","volume":"62","author":"Division of Reproductive Health","year":"2013","journal-title":"MMWR Recomm Rep"},{"issue":"7","key":"10.1016\/j.mcna.2016.03.008_bib49","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1089\/jwh.2012.3955","article-title":"Inappropriate use of combined hormonal contraceptives for birth control among women of reproductive age in the United States","volume":"22","author":"Yu","year":"2013","journal-title":"J\u00a0Womens Health"},{"issue":"1","key":"10.1016\/j.mcna.2016.03.008_bib50","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/09513590.2014.947568","article-title":"Effect of information on the perception of users and prospective users of combined oral contraceptives regarding the risk of venous thromboembolism","volume":"31","author":"Machado","year":"2015","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"10.1016\/j.mcna.2016.03.008_bib51","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1177\/0091270006297919","article-title":"Pharmacokinetics and pharmacodynamics of a transdermal contraceptive patch and an oral contraceptive","volume":"47","author":"Devineni","year":"2007","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"82","key":"10.1016\/j.mcna.2016.03.008_bib52","first-page":"50","article-title":"Ethinylestradiol\u00a0+ etonogestrel contraceptive vaginal ring: new drug. Possibly useful in some situations","volume":"15","year":"2006","journal-title":"Prescrire Int"},{"issue":"1","key":"10.1016\/j.mcna.2016.03.008_bib53","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.beem.2012.11.002","article-title":"Hormonal contraceptives and venous thromboembolism: an epidemiological update","volume":"27","author":"Plu-Bureau","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.mcna.2016.03.008_bib54","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.contraception.2009.12.016","article-title":"ORTHO EVRA and venous thromboembolism: an update","volume":"81","author":"Jick","year":"2010","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.mcna.2016.03.008_bib55","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.contraception.2009.07.004","article-title":"Postmarketing study of ORTHO EVRA and levonorgestrel oral contraceptives containing hormonal contraceptives with 30\u00a0\u03bcg of ethinyl estradiol in relation to nonfatal venous thromboembolism","volume":"81","author":"Jick","year":"2010","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.mcna.2016.03.008_bib56","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.contraception.2006.01.001","article-title":"Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol","volume":"73","author":"Jick","year":"2006","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.mcna.2016.03.008_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003552.pub4","article-title":"Skin patch and vaginal ring versus combined oral contraceptives for contraception","author":"Lopez","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.mcna.2016.03.008_bib58","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009038","article-title":"Triphasic versus monophasic oral contraceptives for contraception","author":"Van Vliet","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.mcna.2016.03.008_bib59","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003989.pub5","article-title":"20\u00a0\u03bcg versus\u00a0>20\u00a0\u03bcg estrogen combined oral contraceptives for contraception","author":"Gallo","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.mcna.2016.03.008_bib60","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clindermatol.2009.03.006","article-title":"Hormonal therapy for acne: why not as first line therapy? facts and controversies","volume":"28","author":"Katsambas","year":"2010","journal-title":"Clin Dermatol"},{"issue":"1","key":"10.1016\/j.mcna.2016.03.008_bib61","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/AOG.0b013e3181cb50b5","article-title":"ACOG Practice Bulletin No. 110: noncontraceptive uses of hormonal contraceptives","volume":"115","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.mcna.2016.03.008_bib62","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ajog.2004.01.004","article-title":"Knowledge of emergency contraception among women aged 18 to 44 in California","volume":"191","author":"Foster","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.mcna.2016.03.008_bib63","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/AOG.0000000000001047","article-title":"Practice Bulletin No. 152: Emergency Contraception","volume":"126","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"RR-04","key":"10.1016\/j.mcna.2016.03.008_bib64","first-page":"1","article-title":"Providing quality family planning services: Recommendations of CDC and the U.S. Office of Population Affairs","volume":"63","author":"Gavin","year":"2014","journal-title":"MMWR Recomm Rep"},{"issue":"5","key":"10.1016\/j.mcna.2016.03.008_bib65","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.contraception.2012.09.011","article-title":"Advance supply of emergency contraception: a systematic review","volume":"87","author":"Rodriguez","year":"2013","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.mcna.2016.03.008_bib66","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0010-7824(02)00351-7","article-title":"Quick start: novel oral contraceptive initiation method","volume":"66","author":"Westhoff","year":"2002","journal-title":"Contraception"},{"issue":"12","key":"10.1016\/j.mcna.2016.03.008_bib67","first-page":"2785","article-title":"A\u00a0prospective, randomized, pharmacodynamic study of quick-starting a desogestrel progestin-only pill following ulipristal acetate for emergency contraception","volume":"30","author":"Brache","year":"2015","journal-title":"Hum Reprod"},{"issue":"12","key":"10.1016\/j.mcna.2016.03.008_bib68","first-page":"2708","article-title":"Starting hormonal contraception after using emergency contraception: what should we recommend?","volume":"30","author":"Glasier","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.mcna.2016.03.008_bib69","unstructured":"ELLA (Ulipristal tablet). Available at: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/022474s007lbl.pdf. Accessed November 29, 2015."},{"issue":"10","key":"10.1016\/j.mcna.2016.03.008_bib70","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3109\/09513590.2014.950648","article-title":"Mechanisms of action of oral emergency contraception","volume":"30","author":"Gemzell-Danielsson","year":"2014","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"10.1016\/j.mcna.2016.03.008_bib71","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0010-7824(98)00042-0","article-title":"New estimates of the effectiveness of the Yuzpe regimen of emergency contraception","volume":"57","author":"Trussell","year":"1998","journal-title":"Contraception"},{"issue":"8","key":"10.1016\/j.mcna.2016.03.008_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001324.pub4","article-title":"Interventions for emergency contraception","author":"Cheng","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.mcna.2016.03.008_bib73","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.contraception.2014.11.001","article-title":"Effect of body weight and BMI on the efficacy of levonorgestrel emergency contraception","volume":"91","author":"Kapp","year":"2015","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.mcna.2016.03.008_bib74","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.contraception.2011.02.009","article-title":"Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel","volume":"84","author":"Glasier","year":"2011","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.mcna.2016.03.008_bib75","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1097\/AOG.0b013e3181deff2a","article-title":"ACOG Practice Bulletin No. 112: Emergency contraception","volume":"115","author":"American College of Obstetricians and Gynecologists","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.mcna.2016.03.008_bib76","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/GME.0000000000000319","article-title":"The North American Menopause Society Recommendations for Clinical Care of Midlife Women","volume":"21","author":"Shifren","year":"2014","journal-title":"Menopause"},{"issue":"4","key":"10.1016\/j.mcna.2016.03.008_bib77","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1001\/jamainternmed.2014.8063","article-title":"Duration of Menopausal Vasomotor Symptoms Over the Menopause Transition","volume":"175","author":"Avis","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"7","key":"10.1016\/j.mcna.2016.03.008_bib78","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.2105\/AJPH.2005.066936","article-title":"Longitudinal Analysis of the Association Between Vasomotor Symptoms and Race\/Ethnicity Across the Menopausal Transition: Study of Women\u2019s Health Across the Nation","volume":"96","author":"Gold","year":"2006","journal-title":"Am J Public Health"},{"issue":"11","key":"10.1016\/j.mcna.2016.03.008_bib79","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1634\/theoncologist.2011-0174","article-title":"Hot flashes: a review of pathophysiology and treatment modalities","volume":"16","author":"Morrow","year":"2011","journal-title":"Oncologist"},{"issue":"10","key":"10.1016\/j.mcna.2016.03.008_bib80","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/GME.0000000000000329","article-title":"Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women\u2019s Sexual Health and the North American Menopause Society","volume":"21","author":"Portman","year":"2014","journal-title":"Menopause"},{"key":"10.1016\/j.mcna.2016.03.008_bib81","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jsbmb.2013.08.015","article-title":"The perimenopausal woman: Endocrinology and management","volume":"142","author":"Hale","year":"2014","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"issue":"3","key":"10.1016\/j.mcna.2016.03.008_bib82","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/gme.0b013e31824b970a","article-title":"The 2012 hormone therapy position statement of: The North American Menopause Society","volume":"19","author":"North American Menopause Society","year":"2012","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.mcna.2016.03.008_bib83","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/01.AOG.0000441353.20693.78","article-title":"ACOG Practice Bulletin No. 141: Management of Menopausal Symptoms","volume":"123","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.mcna.2016.03.008_bib84","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/GME.0000000000000373","article-title":"Algorithm and mobile app for menopausal symptom management and hormonal\/non-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause Society","volume":"22","author":"Manson","year":"2015","journal-title":"Menopause"},{"issue":"4","key":"10.1016\/j.mcna.2016.03.008_bib85","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/AOG.0000000000001058","article-title":"Management of Menopausal Symptoms","volume":"126","author":"Kaunitz","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.mcna.2016.03.008_bib86","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000402.pub4","article-title":"Hormone therapy in postmenopausal women and risk of endometrial hyperplasia","author":"Furness","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.mcna.2016.03.008_bib87","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/GME.0000000000000258","article-title":"Low-dose transdermal estradiol for vasomotor symptoms: a systematic review","volume":"22","author":"Corbelli","year":"2015","journal-title":"Menopause"},{"issue":"4","key":"10.1016\/j.mcna.2016.03.008_bib88","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.maturitas.2015.01.003","article-title":"Perspective on prescribing conjugated estrogens\/bazedoxifene for estrogen-deficiency symptoms of menopause: A\u00a0practical guide","volume":"80","author":"Palacios","year":"2015","journal-title":"Maturitas"},{"key":"10.1016\/j.mcna.2016.03.008_bib89","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2147\/IJWH.S50804","article-title":"Critical appraisal of paroxetine for the treatment of vasomotor symptoms","volume":"7","author":"Carroll","year":"2015","journal-title":"Int J Womens Health"},{"issue":"17","key":"10.1016\/j.mcna.2016.03.008_bib90","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1001\/jama.295.17.2057","article-title":"Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis","volume":"295","author":"Nelson","year":"2006","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.mcna.2016.03.008_bib91","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ogc.2014.09.008","article-title":"Hormonal and nonhormonal treatment of vasomotor symptoms","volume":"42","author":"Krause","year":"2015","journal-title":"Obstet Gynecol Clin North A"},{"issue":"11","key":"10.1016\/j.mcna.2016.03.008_bib92","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/GME.0000000000000546","article-title":"Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society","volume":"22","year":"2015","journal-title":"Menopause"},{"issue":"9","key":"10.1016\/j.mcna.2016.03.008_bib93","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/GME.0b013e3182a122c2","article-title":"Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society","volume":"20","year":"2013","journal-title":"Menopause"},{"issue":"4","key":"10.1016\/j.mcna.2016.03.008_bib94","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001500.pub2","article-title":"Local oestrogen for vaginal atrophy in\u00a0postmenopausal women","author":"Suckling","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.mcna.2016.03.008_bib95","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1016\/j.clon.2012.06.009","article-title":"Are Estring\u00ae and Vagifem\u00ae equally effective and safe for the treatment of urogenital atrophy in breast cancer patients on aromatase inhibitor therapy?","volume":"24","author":"Simmons","year":"2012","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"2","key":"10.1016\/j.mcna.2016.03.008_bib96","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10549-012-2198-y","article-title":"Local estrogen therapy and risk of breast cancer recurrence among hormone-treated patients: a nested case-control study","volume":"135","author":"Le Ray","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"10.1016\/j.mcna.2016.03.008_bib97","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1177\/1933719113497290","article-title":"Profile of ospemifene in the breast","volume":"20","author":"Berga","year":"2013","journal-title":"Reprod Sci"},{"issue":"3","key":"10.1016\/j.mcna.2016.03.008_bib98","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.maturitas.2013.07.009","article-title":"Contraception during the perimenopause","volume":"76","author":"Baldwin","year":"2013","journal-title":"Maturitas"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712516000389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712516000389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,8]],"date-time":"2019-09-08T22:02:09Z","timestamp":1567980129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712516000389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":98,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0025712516000389"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2016.03.008","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacologic Therapies in Women\u2019s Health","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2016.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}